Role of the cell-mediated immune response in the pathogenesis of hepatitis B virus infection: Possible immune-therapeutic strategies

Acta Biomedica de l'Ateneo Parmense

Volumn 67, Issue 3-4, 1996, Pages 87-93

  Bertoletti, Antonio ^a   Ferrari, Carlo ^b   Fiaccadori, Franco ^b  

^a Azienda Ospedaliera   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

CONFERENCE PAPER; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; PATHOGENESIS; T LYMPHOCYTE; VIRUS HEPATITIS; VIRUS INFECTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; HEPATITIS B; HEPATITIS B VACCINES; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR;

EID: 0029805625     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. BERTOLETTI A., C. FERRARI, F. FIACCADORI, A. PENNA, R. MARGOLSKEE, H.J. SCHLICHT, P. FOWLER, S. GUILHOT, AND F.V. CHISARI. HLA class-I human cytotoxic T cell recognize endogenously synthesized hepatitus B virus nucleocapsid antigen. Proc. Natl. Acad. Sci. USA 88, 10445, 1991.
2. BERTOLETTI A., CHISARI F.V., PENNA A., GUILHOT S., GALATI L., MISSALE G., FOWLER P., SCHLICHT H.-J., VITIELLO A., CHESNUT R., FIACCADORI F. AND FERRARI C. Definition of an optimal cytotoxic T cell epitope within the hepatitis B virus micleocapsid protein. J. Virol. 67, 2376, 1993.
3. CHISARI F.V. AND FERRARI C. Hepatitis B virus immunopathogenesis. Ann. Rev. Immunol., 13, 29, 1995.
4. DERES K., SCHILD H., WIESMULLER K-H, JUNG G. AND RAMMENSEE H.-G. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342, 561, 1989.
5. DOHERTY P.C., ALLAN W., EICHELBERGER M. Roles of ab and gd T cell subsets in viral immunity. Ann. Rev. Immunol. 10, 123, 1992.
6. GERMAIN R.N. MHC. Dependent antigen processing and peptide presentation: providing ligands for T lymohocyte activation. Cell. 76, 287, 1994.
7. GUIDOTTI LG, ANDO K., HOBBS MV, ISHIKAVA T., RUNKEL L, R.D. SCHREINER, CHISARI FV. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolitic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA.; 91: 3764-3768, 1994.
8. MARRACK P. AND KAPPLER J. Subversion of the immune system by pathogens. Cell. 76, 323, 1994.
9. MATSUMURA M., FREMONT D.H. AND PETERSON P.A. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257, 927, 1992.
10. MISSALE G., REDEKER A., PERSON J., FOWLER P., GUILHOT S., SCHLICHT H.-J., FERRARI C., AND CHISARI F.V. HLA-A31 and HLA-Aw68 restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med. 177, 751, 1993.
11. MARRACK M., FREMONT D.H. AND PETERSON P.A. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257, 927, 1992.
12. MORSYAMA T., GUILHOT S., KLOPCHIN K. AND CHISARI F.V. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248, 361, 1990
13. NAYERSINA R., FOWLER P, GUILHOT S., MISSALE G., CERNY A., SCHLICHT H.-J., VITIELLO A., CHESNUT R., PERSON J.L., REDECKER A.G. AND CHISARI F.V. HLA-A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150, 4659, 1993.
14. PENNA A., CHISARI F.V., BERTOLETTI A., MISSALE G., FOWLER P., GIUBERTI T., FIACCADORI F., AND FERRARI C. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. 174, 1565, 1991.
15. REHERMANN B., PERSON J., REDEKER A., FOWLER P., BROWN M., SETTE A, MOSS B., CHISARI F.V The cytotoxic T lymphocyte response to multiple hepatitis B virus polymersae epitopes during and after acute viral hepatitis. J. Exp. Med. 181, 1047, 1995
16. TOWSEND A.R.M., ROTHBARD J., GOTCH F.M. AND A.J. MC MICHAEL, The epitopes of influenza nucleoprotein recognized by cytotoxic T limphocytes can be defined with short synthetic peptides. Cell. 44, 959, 1986.
17. VITIELLO A., ISHIOTA G., GREY H.M., ROSE R., FARNESS P., LAFOND R., YUAN L., CHESNUT R. Development of a lipopeptide-based vaccine to tret chronic HBV infection. I. Iaduction of a primary cytotoxic T lymphocyte response in humans. J. Clin. Invest. 1, 341, 1995.